Dry powder Inhaler comprising salmeterol xinafoate and Fluticasone propionate

摘要

Refers to a dry powder Inhaler comprises a dry powder, characterized in that it comprises Fluticasone propionateSalmeterol xinafoate and a lactose Carrier; whereinThe administered dose of Fluticasone propionate is less than 100 micrograms per Drive; and where the FEV1 adjusted dose provides a home in a patient over 150 ml within dAnd 30 minutes after receiving the dose. It also relates to a method of Treatment